Pular para o conteúdo
Tumor embrionário com rosetas multicamadas
ORPHA:656417CID-10 · C71.9CID-11 · XH0KZ2DOENÇA RARA
Também conhecida comoETMR
Sinônimos clínicos: ETMR

Um tumor embrionário raro do sistema nervoso central caracterizado por células embrionárias dispostas em rosetas multicamadas e exibindo um de três padrões morfológicos: tumor embrionário com neurópilo abundante e rosetas verdadeiras, ependimoblastoma ou meduloepitelioma. Os tumores apresentam tipicamente uma alteração no C19MC ou (raramente) uma mutação no DICER1 e correspondem ao grau IV da OMS. Eles localizam-se predominantemente no interior do crânio, raramente na medula espinhal, e comumente causam sinais e sintomas de pressão intracraniana elevada, algumas vezes convulsões e sinais neurológicos focais. A maioria dos casos ocorre em crianças durante os primeiros dois anos de vida.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

Mantido pelo Disease Twin100% com fonte · atualizado 27/09/2026Revisão médica pendente
Informacoes curadas por IA — podem conter imprecisoes

Visão geral

O tumor embrionário com rosetas multicamadas é uma neoplasia embrionária rara do sistema nervoso central, classificada como grau IV pela OMS. O quadro se caracteriza histologicamente por células embrionárias organizadas em rosetas multicamadas, exibindo um de três padrões morfológicos: tumor embrionário com neurópilo abundante e rosetas verdadeiras, ependimoblastoma ou meduloepitelioma. A maioria dos casos acomete crianças durante os primeiros dois anos de vida.[1]

Sinais e sintomas

Esses tumores localizam-se predominantemente no interior do crânio e, de forma rara, na medula espinhal. Comumente, manifestam-se por meio de sinais e sintomas associados à pressão intracraniana elevada, além de poderem apresentar convulsões e sinais neurológicos focais.[1]

Causas genéticas

Do ponto de vista genético, as alterações características desses tumores envolvem tipicamente modificações no C19MC ou, mais raramente, mutações no gene DICER1.[1]

Tratamento e manejo

No âmbito do Sistema Único de Saúde (SUS), o PCDT vigente relacionado a 'Tumor Cerebral no Adulto' (Portaria Conjunta SAES-SCTIE/MS nº 07, de 13 de abril de 2020) prevê a conduta terapêutica conforme a autonomia do serviço médico responsável, sem a determinação de medicamentos dispensados padronizados especificamente para esta condição rara nos dados catalogados.[2]

Fontes numeradas em Referências.

Conteúdo informativo gerado e mantido automaticamente a partir de fontes oficiais (Orphanet, HPO, OMIM, SUS). Não substitui avaliação médica.

💬
EM LINGUAGEM SIMPLES

O tumor embrionário com rosetas multicamadas (ETMR) é um tumor cerebral raro e de alto grau que atinge principalmente bebês e crianças nos primeiros dois anos de vida. Ele costuma provocar sintomas decorrentes da pressão alta na cabeça, além de possíveis **convulsões** (crises epilépticas) e alterações neurológicas. O diagnóstico é confirmado pela análise das células em rosetas e pela verificação de alterações genéticas como no C19MC. No Sistema Único de Saúde (SUS), o atendimento a tumores cerebrais segue o protocolo clínico com condutas dispensadas conforme a autonomia do serviço médico.

Informacoes curadas por IA — podem conter imprecisoes
[1] Orphanet [17] PCDT vigente "Tumor Cerebral no Adulto…
📋
Informacoes curadas por IA — podem conter imprecisoes

Um tumor embrionário raro do sistema nervoso central caracterizado por células embrionárias dispostas em rosetas multicamadas e exibindo um de três padrões morfológicos: tumor embrionário com neurópilo abundante e rosetas verdadeiras, ependimoblastoma ou meduloepitelioma. Os tumores apresentam tipicamente uma alteração no C19MC ou (raramente) uma mutação no DICER1 e correspondem ao grau IV da OMS. Eles localizam-se predominantemente no interior do crânio, raramente na medula espinhal, e comumente causam sinais e sintomas de pressão intracraniana elevada, algumas vezes convulsões e sinais neurológicos focais. A maioria dos casos ocorre em crianças durante os primeiros dois anos de vida.

Pesquisas ativas
7 ensaios
9 total registrados no ClinicalTrials.gov
Publicações científicas
109 artigos
Último publicado: 1993
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C71.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico109PubMed
Últimos 10 anos94publicações
Pico202217 papers
Linha do tempo
2026Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 24
1Fase 14
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 9 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor embrionário com rosetas multicamadas

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 2 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

7 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

9 ensaios clínicos encontrados, 7 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
96 papers (10 anos)
#1

Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings.

Virchows Archiv : an international journal of pathology2026 Mar 12

In the latest version of the World Health Organization Classification (WHO) of Central Nervous System Tumors, the terminology "medulloepithelioma" has disappeared as a distinct tumor type in favor of "embryonal tumor with multilayered rosettes (ETMR)", characterized by frequent alterations of C19MC. However, medulloepithelioma persists in the current WHO classification of eye tumors, where two variants exist (teratoid and non-teratoid), harboring frequent DICER1 mutations. DNA-methylation profiling has demonstrated that ETMR and intraocular medulloepitheliomas represented two distinct methylation classes. Outside the CNS and the eye, exceptional observations of medulloepitheliomas have been reported, most of them before the genetic and epigenetic eras. Herein, we report a pediatric case of a presacral tumor classified as a teratoid medulloepithelioma with genetic and epigenetic charaterizations. Using DNA-methylation profiling analysis, the tumor was classified between ETMR, non C19MC-altered, and intra-ocular medulloepithelioma, arguing for a potential distinct cell origin, not represented in the current epigenetic classifiers.

#2

DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like Tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2026 Jan

Gynecologic neuroectodermal tumors either exhibit central nervous system (CNS) differentiation (CNS-like) or represent Ewing sarcoma (EWS), which lacks CNS features and harbors FET-ETS gene fusions. DNA methylation profiling reclassified CNS primitive neuroectodermal tumors into common CNS neoplasms or embryonal tumors with specific epigenetic/genetic characteristics. Its utility in classifying gynecologic neuroectodermal tumors is unknown. Whole-genome DNA methylation profiling was performed on 26 gynecologic neuroectodermal tumors (22 CNS-like tumors, 4 EWS) arising in the ovary, paratubal soft tissue, uterus, and vulva, which were classified by using sarcoma and CNS tumor DNA methylation classifiers. Sarcoma-related gene fusions were confirmed by fluorescence in situ hybridization or targeted RNA next-generation sequencing. Tumor-only whole-exome sequencing (WES) was performed in 13 cases. Copy number alterations and zygosity were inferred from DNA methylation array and WES data. Methylation abnormalities associated with imprinting were examined. The sarcoma methylation classifier identified EWS (n = 3) and high-grade endometrial stromal sarcoma (n = 1), confirmed by fluorescence in situ hybridization or next-generation sequencing detection of EWSR1 and YWHAE rearrangements, respectively. The remaining CNS-like tumors were classified by DNA methylation with positive/valid (n = 4), indeterminate (n = 9), and negative (n = 9) scores at the family level. Methylation subclasses included teratoma; embryonal tumor with multilayered rosettes, atypical; medulloblastoma, SHH-activated, subtype 3; medulloblastoma, group 3; intraocular medulloepithelioma; supratentorial ependymoma, ZFTA::RELA fused, subclass A; and diffuse pediatric-type high-grade glioma, MYCN subtype. Male biological sex was predicted in 54% of methylation-confirmed CNS-like tumors and none of the sarcomas. Among CNS-like tumors, copy number analyses identified genome-wide chromosomal gains and losses, and WES revealed genome-wide allelic imbalance suggestive of genome-wide duplications. Epigenetic imprinting analyses showed increased paternal or maternal imprinting signal across multiple chromosomes, suggesting uniparental duplication. DNA methylation profiling successfully classified gynecologic neuroectodermal tumors as known CNS tumors or sarcoma entities. Epigenetic and exomic studies indicate a male genome and increased maternal allelic contribution in CNS-like tumors, suggesting development via conception or chimerism.

#3

Central Nervous System Embryonal Tumors.

Neuroimaging clinics of North America2026 Feb

Central nervous system (CNS) embryonal tumors are a subset of aggressive pediatric brain tumors, more frequently seen in infants and young children. They share an aggressive imaging appearance with frequent disseminated disease and guarded prognosis; however, patient age, tumor location, and imaging characteristics such as enhancement pattern and peritumoral edema can help with differential diagnosis. In this article, we have reviewed medulloblastoma, atypical teratoid rhabdoid tumor, embryonal tumor with multilayered rosettes as well as newly recognized CNS neuroblastoma, FOXR2-activated and CNS tumor with BCOR internal tandem duplication.

#4

ETMR stem-like state and chemo-resistance are supported by perivascular cells at single-cell resolution.

Nature communications2025 Jun 25

Embryonal tumor with multilayered rosettes (ETMR) is a lethal embryonal brain tumor entity. To investigate the intratumoral heterogeneity and cellular communication in the tumor microenvironment (TME), we analyze in this work single-cell RNA sequencing of about 250,000 cells of primary human and murine ETMR, in vitro cultures, and a 3D forebrain organoid model of ETMR, supporting the main findings with immunohistochemistry and spatial transcriptomics of human tumors. We characterize three distinct malignant ETMR subpopulations - RG-like, NProg-like and NB-like - positioned within a putative neurodevelopmental hierarchy. We reveal PDGFRβ+ pericytes as key communication partners in the TME, contributing to stem cell signaling through extracellular matrix-mediated interactions with tumor cells. PDGF signaling is upregulated in chemoresistant RG-like cells in vivo and plays a role in recruiting pericytes to ETMR TME by finalizing a signaling cascade which promotes the differentiation of non-malignant radial glia cells, derived from our 3D model, into pericyte-like cells. Selective PDGFR-inhibition blocked the lineage differentiation into pericytes in vitro and reduced the tumor cell population in vivo. Targeting ETMR-pericyte interactions in the TME presents a promising therapeutic approach.

#5

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Nature cancer2025 Jun

Embryonal tumor with multilayered rosettes (ETMR) is a pediatric brain tumor with dismal prognosis. Characteristic alterations of the chromosome 19 microRNA cluster (C19MC) are observed in most ETMR; however, the ramifications of C19MC activation and the complex cellular architecture of ETMR remain understudied. Here we analyze 11 ETMR samples from patients using single-cell transcriptomics and multiplexed spatial imaging. We reveal a spatially distinct cellular hierarchy that spans highly proliferative neural stem-like cells and more differentiated neuron-like cells. C19MC is predominantly expressed in stem-like cells and controls a transcriptional network governing stemness and lineage commitment, as resolved by genome-wide analysis of microRNA-mRNA binding. Systematic analysis of receptor-ligand interactions between malignant cell types reveals fibroblast growth factor receptor and Notch signaling as oncogenic pathways that can be successfully targeted in preclinical models and in one patient with ETMR. Our study provides fundamental insights into ETMR pathobiology and a powerful rationale for more effective targeted therapies.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC64 artigos no totalmostrando 94

2026

Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings.

Virchows Archiv : an international journal of pathology
2025

YAP1::MAML2 fusion, a newly identified genetic anomaly in a posterior fossa infant tumor, associated with the methylation class "embryonal tumor with multilayered rosettes, non-C19MC-altered" in the Heidelberg central nervous system tumor classifier and "embryonal tumor with multilayered rosettes-DICER" in the NIH classifier.

Acta neuropathologica communications
2026

DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like Tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2026

Central Nervous System Embryonal Tumors.

Neuroimaging clinics of North America
2025

Rare and aggressive: A case of embryonal tumor with multilayered rosettes (ETMR) in a young child.

Radiology case reports
2025

Outcomes of Infants and Young Children With CNS Embryonal Tumors Using Pre-Irradiation Chemotherapy: A Decade Long Experience.

Cancer medicine
2025

ETMR stem-like state and chemo-resistance are supported by perivascular cells at single-cell resolution.

Nature communications
2025

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology Group.

Neuro-oncology
2025

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Nature cancer
2025

Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR).

Journal of neuro-oncology
2025

Exploring Maintenance Therapy in Pediatric Embryonal Tumor With Multilayered Rosettes.

Journal of pediatric hematology/oncology
2025

Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.

Human pathology
2025

Evaluating the efficacy of radiotherapy in patients with embryonal tumor with multilayered rosettes: A systematic review and meta-analysis.

Neuro-oncology practice
2025

Embryonal tumor with multilayered rosettes, DICER1-mutated, showing histologically unique neuronal differentiation after chemoradiotherapy.

Neuropathology : official journal of the Japanese Society of Neuropathology
2024

Pediatric skull base tumors: Clinical features and surgical outcomes; a single center retrospective study with a review of literature.

Brain & spine
2024

Cerebrospinal fluid liquid biopsy by low-pass whole genome sequencing for clinical disease monitoring in pediatric embryonal tumors.

Neuro-oncology advances
2024

DICER1-sarcomas of GYN tract: Expanding on an emerging entity.

Human pathology
2024

[Embryonal tumor with multilayered rosettes: a clinicopathological analysis of three cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2024

Non-C19MC-altered embryonal tumor with multilayered rosettes in a young woman with DICER1 syndrome: case report and review of the literature.

Pathologica
2024

Genetic mutation and immune infiltration in embryonal tumor with multilayered rosettes.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Case of embryonal tumor multilayered rosettes in a patient with neurofibromatosis type 1.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Embryonal tumor with multilayered rosettes located in the brainstem: Promising results after multimodal treatment including interstitial brachytherapy.

Neuro-oncology practice
2023

Embryonal Tumor with Multilayered Rosettes, NOS of Cervical Spinal Cord.

Neurology India
2024

Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes.

Neuro-oncology
2023

Methylation-based Subclassifications of Embryonal Tumor with Multilayered Rosettes in Not Just Pediatric Brains.

Experimental neurobiology
2024

Embryonal tumor with multilayered rosettes arising from the internal auditory canal of an adult: Illustrative case with molecular investigations.

Neuropathology : official journal of the Japanese Society of Neuropathology
2023

Embryonal tumor with multilayered rosettes: Overview of diagnosis and therapy.

Neuro-oncology advances
2023

Medulloblastomas, CNS embryonal tumors, and cerebellar mutism syndrome: advances in care and future directions.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2023

Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.

Advances in experimental medicine and biology
2023

Current Open Trials and Molecular Update for Pediatric Embryonal Tumors.

Pediatric neurosurgery
2023

Embryonal tumor with multilayered rosettes: Post-treatment maturation and implications for future therapy.

Cancer reports (Hoboken, N.J.)
2023

Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.

Neuro-oncology
2023

[Imaging findings of supratentorial embryonal tumor with multilayered rosettes in children].

Zhonghua yi xue za zhi
2022

Embryonal tumor with multilayered rosettes: a report of a rare case.

BJR case reports
2022

Clinical Management of Embryonal Tumor with Multilayered Rosettes: The CCMC Experience.

Children (Basel, Switzerland)
2022

Embryonal tumor with multilayered rosettes; rare pediatric CNS tumor. A case report and review of literature.

International journal of pediatrics & adolescent medicine
2022

Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.

Acta neuropathologica
2022

Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology.

Pathology international
2022

[Embryonal tumor with multilayered rosettes (ETMR): case report and literature review].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2022

Germ cell tumors with neuroglial differentiation do not show molecular features akin to their central nervous system counterpart: experience from extra-gynecological sites.

Virchows Archiv : an international journal of pathology
2022

Prognostic impact of the multimodal treatment approach in patients with C19MC-altered embryonal tumor with multilayered rosettes.

Journal of neurosurgery. Pediatrics
2022

Embryonal tumors in the WHO CNS5 classification: A Review.

Indian journal of pathology & microbiology
2022

Embryonal tumor with multilayered rosettes in a teenager.

Autopsy & case reports
2022

Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.

Neuro-oncology
2022

Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2022

Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).

Neuro-oncology
2022

A 2-year-old girl with posterior fossa mass.

Brain pathology (Zurich, Switzerland)
2022

DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2021

DICER1-associated malignancies mimicking germ cell neoplasms: Report of two cases and review of the literature.

Pathology, research and practice
2022

A surgical case of pediatric spinal medulloepithelioma.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2021

A pediatric cerebral tumor with MN1 alteration and pathological features mimicking carcinoma metastasis: may the terminology "high grade neuroepithelial tumor with MN1 alteration" still be relevant?

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2021

Clinicopathological characteristics and outcomes in embryonal tumor with multilayered rosettes: A decade long experience from a tertiary care centre in North India.

Annals of diagnostic pathology
2021

Retrobulbar embryonal tumor with multilayered rosettes in a golden retriever dog.

Clinical case reports
2022

Embryonal Tumor With Multilayered Rosettes of the Parietooccipital Region: A Case Report.

Journal of pediatric hematology/oncology
2020

Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes.

Frontiers in oncology
2021

C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2020

Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.

Surgical pathology clinics
2020

Transcriptomic Analysis Revealed an Emerging Role of Alternative Splicing in Embryonal Tumor with Multilayered Rosettes.

Genes
2021

Embryonal tumor with multilayered rosettes, C19MC-altered with sarcomatous differentiation: histopathologic and molecular characterization of one case.

Clinical neuropathology
2020

ETMR: a tumor entity in its infancy.

Acta neuropathologica
2020

Embryonal Tumors of the Central Nervous System: An Update.

Surgical pathology clinics
2020

Pontine Embryonal Tumor With Multilayered Rosettes: An Autopsy Case Exhibiting Extensive Posttreatment Glial and Neuronal Maturation.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2019

Embryonal tumor with multilayered rosettes, C19MC-altered (ETMR): a newly defined pediatric brain tumor.

International journal of clinical and experimental pathology
2020

Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.

Pediatric blood & cancer
2019

Molecular pathology of tumors of the central nervous system.

Annals of oncology : official journal of the European Society for Medical Oncology
2019

Integration of a Personalized Molecular Targeted Therapy into the Multimodal Treatment of Refractory Childhood Embryonal Tumor with Multilayered Rosettes (ETMR).

Case reports in oncology
2019

Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.

Diagnostic pathology
2019

Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.

Journal of neuro-oncology
2020

Advances in Diagnostic Immunohistochemistry for Primary Tumors of the Central Nervous System.

Advances in anatomic pathology
2019

Medulloepithelioma with heterologous osteoid component: a case report and review of literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2018

Embryonal tumor with multilayered rosettes: illustrative case and review of the literature.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2018

Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.

The American journal of surgical pathology
2017

Rare Brain Tumor in a Neonate.

Journal of medical ultrasound
2018

Embryonal Tumor with Multilayered Rosettes Presenting with Intermittent Third Nerve Palsy.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2018

Embryonal Tumor with Multilayered Rosettes, C19MC-Altered: Clinical, Pathological, and Neuroimaging Findings.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2018

Four Levels of Diagnosis in the Rare Pediatric Embryonal Tumor of the CNS Called Embryonal Tumor with Multilayered Rosettes.

Radiographics : a review publication of the Radiological Society of North America, Inc
2018

Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.

Radiographics : a review publication of the Radiological Society of North America, Inc
2018

Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics.

Advances in anatomic pathology
2018

Embryonal tumor with multilayered rosettes: Diagnosis on intra-operative squash smear.

Neuropathology : official journal of the Japanese Society of Neuropathology
2019

A Congenital Case of Ependymoblastoma: A Rare and Aggressive Brain Tumor.

Journal of pediatric hematology/oncology
2017

Embryonal tumor with multilayered rosettes, C19MC-altered: Report of an extremely rare malignant pediatric central nervous system neoplasm.

SAGE open medical case reports
2017

A Simplified Overview of World Health Organization Classification Update of Central Nervous System Tumors 2016.

Journal of neurosciences in rural practice
2018

Extracranial extra-CNS spread of embryonal tumor with multilayered rosettes (ETMR): case series and systematic review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2017

LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT).

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2017

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.

Neurologia medico-chirurgica
2017

Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.

Neuro-oncology
2017

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.

Neuro-oncology
2019

Embryonal Tumor with Multilayered Rosettes in a 3-Year-Old Girl: Case Report.

Turkish neurosurgery
2016

Atypical teratoid/rhabdoid tumors with multilayered rosettes in the pineal region.

Brain tumor pathology
2017

Overexpression of Lin28b in Neural Stem Cells is Insufficient for Brain Tumor Formation, but Induces Pathological Lobulation of the Developing Cerebellum.

Cerebellum (London, England)
2015

[Clinicopathologic features of embryonal tumor with multilayered rosettes and gene analysis on chromosome 19q13.42].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2015

Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2015

Embryonal tumor with multilayered rosettes of the fourth ventricle: case report.

Journal of neurosurgery. Pediatrics
2015

Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.

Neuropathology : official journal of the Japanese Society of Neuropathology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor embrionário com rosetas multicamadas.

É de uma associação que acompanha esta doença? Fale com a gente →

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É um tumor embrionário raro e agressivo do sistema nervoso central, classificado como grau IV pela OMS. Ele acomete principalmente crianças pequenas nos dois primeiros anos de vida e caracteriza-se por células em rosetas multicamadas.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

4 fontes citadas no texto · 7 publicações do grafo RarasNet (PubMed) · 3 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. MONDO
    purl.obolibrary.org
  2. DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like Tumors.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2026PMID 41285250
  3. Central Nervous System Embryonal Tumors.
    Neuroimaging clinics of North America2026PMID 41274772
  4. GARD:6352
    GARD (NIH)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (2026). Tumor embrionário com rosetas multicamadas. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/tumor-embrionario-com-rosetas-multicamadas

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Tumor embrionário com rosetas multicamadas

ORPHA:656417 · MONDO:0958119
CID-10
C71.9 · Neoplasia maligna do encéfalo, não especificado
CID-11
Ensaios
7 ativos
MedGen
UMLS
C5575350
EuropePMC
Papers 10a
Evidência
🥉 Relato de caso

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Rara